TP53 and breast cancer: It has been proposed that a CD44high phenotype correlates with over-expression of mutated p53 in tumor tissue [18], [19], suggesting that inactivated p53 expression can aid the survival of immortalized, premalignant cells and may also correlate with the level of in vivo tumorigenicity of breast cancer cells [19], [20].